BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 8157707)

  • 1. Renal 11 beta-hydroxysteroid dehydrogenase activity is enhanced by ramipril and captopril.
    Riddle MC; McDaniel PA
    J Clin Endocrinol Metab; 1994 Apr; 78(4):830-4. PubMed ID: 8157707
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulation of 11beta-hydroxysteroid dehydrogenase type 2 by diuretics and the renin-angiotensin-aldosterone axis.
    Ricketts ML; Stewart PM
    Clin Sci (Lond); 1999 Jun; 96(6):669-75. PubMed ID: 10334975
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Renal tissue angiotensins during converting enzyme inhibition of angiotensin I in spontaneously hypertensive rat].
    Ingert C; Grima M; Michel B; Barthelmebs M; Imbs JL
    Arch Mal Coeur Vaiss; 1997 Aug; 90(8):1135-41. PubMed ID: 9404423
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Threshold sodium excretory and renal blood flow effects of angiotensin converting enzyme inhibition.
    Zhang X; Dunham EW; Zimmerman BG
    J Hypertens; 1995 Dec; 13(12 Pt 1):1413-19. PubMed ID: 8866903
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acute reduction of renal 11 beta-hydroxysteroid dehydrogenase activity by several antinatriuretic stimuli.
    Riddle MC; McDaniel PA
    Metabolism; 1993 Oct; 42(10):1370-4. PubMed ID: 8412753
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of renal 11beta-hydroxysteroid dehydrogenase in vivo by carbenoxolone in the rat and its relationship to sodium excretion.
    Sewell KJ; Shirley DG; Michael AE; Thompson A; Norgate DP; Unwin RJ
    Clin Sci (Lond); 1998 Oct; 95(4):435-43. PubMed ID: 9748419
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Effects of conversion enzyme inhibitors on the synthesis of angiotensin II by the isolated rat kidney].
    Krieger JP; Welsch C; Giesen-Crouse E; Schmidt M; Imbs JL
    Arch Mal Coeur Vaiss; 1987 Jun; 80(6):862-5. PubMed ID: 2959231
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro tissue potencies of converting enzyme inhibitors. Prodrug activation by kidney esterase.
    Grima M; Welsch C; Michel B; Barthelmebs M; Imbs JL
    Hypertension; 1991 Apr; 17(4):492-6. PubMed ID: 2013476
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 11 beta-hydroxysteroid dehydrogenase in vascular smooth muscle and heart: implications for cardiovascular responses to glucocorticoids.
    Walker BR; Yau JL; Brett LP; Seckl JR; Monder C; Williams BC; Edwards CR
    Endocrinology; 1991 Dec; 129(6):3305-12. PubMed ID: 1954906
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of renal hemodynamic effect of ramiprilat to captopril; possible role of kinins.
    Chen K; Zimmerman BG
    J Pharmacol Exp Ther; 1994 Aug; 270(2):491-7. PubMed ID: 8071842
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of carbenoxolone administered acutely to adrenalectomized rats (in vivo) on renal and hepatic handling of corticosterone by 11 beta-hydroxysteroid dehydrogenase.
    Latif SA; Semafuko WE; Morris DJ
    Steroids; 1992 Oct; 57(10):494-501. PubMed ID: 1455457
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glucocorticoid metabolism in the cardiac interstitium: 11 beta-hydroxysteroid dehydrogenase activity in cardiac fibroblasts.
    Slight S; Ganjam VK; Nonneman DJ; Weber KT
    J Lab Clin Med; 1993 Aug; 122(2):180-7. PubMed ID: 8340703
    [TBL] [Abstract][Full Text] [Related]  

  • 13. LLC-PK1 cells model 11 beta-hydroxysteroid dehydrogenase type 2 regulation of glucocorticoid access to renal mineralocorticoid receptors.
    Leckie C; Chapman KE; Edwards CR; Seckl JR
    Endocrinology; 1995 Dec; 136(12):5561-9. PubMed ID: 7588309
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tissue-specific distribution of the NAD(+)-dependent isoform of 11 beta-hydroxysteroid dehydrogenase.
    Walker BR; Campbell JC; Williams BC; Edwards CR
    Endocrinology; 1992 Aug; 131(2):970-2. PubMed ID: 1639034
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of 11 beta-hydroxysteroid dehydrogenase enzymes in the rat kidney by estradiol.
    Gomez-Sanchez EP; Ganjam V; Chen YJ; Liu Y; Zhou MY; Toroslu C; Romero DG; Hughson MD; de Rodriguez A; Gomez-Sanchez CE
    Am J Physiol Endocrinol Metab; 2003 Aug; 285(2):E272-9. PubMed ID: 12700160
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of angiotensin converting enzyme inhibitors on cardiac noradrenaline release.
    Richardt G; Kranzhöfer R; Schömig A
    Eur Heart J; 1991 Dec; 12 Suppl F():121-3. PubMed ID: 1804631
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Developmental changes in rat renal 11 beta-hydroxysteroid dehydrogenase.
    Brem AS; Bina B; Matheson KL; Barnes JL; Morris DJ
    Kidney Int; 1994 Mar; 45(3):679-83. PubMed ID: 8196270
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of the 11 beta-hydroxysteroid dehydrogenase in the rat adrenal. Decrease enzymatic activity induced by ACTH.
    Morita H; Cozza EN; Zhou MY; Gomez-Sanchez EP; Romero DG; Gomez-Sanchez CE
    Endocrine; 1997 Dec; 7(3):331-5. PubMed ID: 9657070
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Renal 11 beta-hydroxysteroid dehydrogenase activity: effects of age, sex and altered hormonal status.
    Smith RE; Funder JW
    J Steroid Biochem Mol Biol; 1991 Feb; 38(2):265-7. PubMed ID: 2004048
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Licorice inhibits 11 beta-hydroxysteroid dehydrogenase messenger ribonucleic acid levels and potentiates glucocorticoid hormone action.
    Whorwood CB; Sheppard MC; Stewart PM
    Endocrinology; 1993 Jun; 132(6):2287-92. PubMed ID: 8504732
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.